Bausch Health Companies | VRX - Umsatzerlöse

Aktienkurs
7.42
Täglich Wechseln
0.09 1.16%
Monatlich
-6.02%
Jährlich
13.90%
Q2 Prognose
7.72




Der Umsatz Veränderung Datum
Amgen USD 8.62B 1.28B 2026-03
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bausch Health Companies USD 2.5B 300M 2026-03
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Danaher USD 5.95B 890M 2026-03
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7B 930M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novo Nordisk DKK 96.82B 17.68B 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 969M 141M 2026-03
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Zoetis USD 2.3B 100M 2026-03